11721 related articles for article (PubMed ID: 1270047)
1. [Immunology of malignant melanomas].
Schieferstein G
Fortschr Med; 1976 May; 94(14):833-7. PubMed ID: 1270047
[TBL] [Abstract][Full Text] [Related]
2. Proliferation pattern of hamster melanoma cells cultured in diffusion chambers in pre-immunized hosts.
Schieferstein G; Laerum OD
Arch Dermatol Forsch; 1975; 251(3):169-80. PubMed ID: 1115522
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
[TBL] [Abstract][Full Text] [Related]
4. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
5. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
6. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
7. Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivity.
Berkelhammer J; Ensign BM; Hook RR; Hecker CJ; Smith GD; Oxenhandler RW
J Natl Cancer Inst; 1982 Mar; 68(3):461-8. PubMed ID: 6950174
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
9. Estimation of macrophage IL-10 and NO secretion in the cytotoxicity against transplantable melanomas in relation to the progression of these tumours.
Kozłowska K; Cichorek M; Zarzeczna M
Folia Morphol (Warsz); 2002; 61(3):127-31. PubMed ID: 12416926
[TBL] [Abstract][Full Text] [Related]
10. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
[TBL] [Abstract][Full Text] [Related]
11. Immunology and immunotherapy of human malignant melanoma.
Bystryn JC
Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
13. [Proceeding a protein factor re-establishing the contact-inhibition of hamster melanoma cells in vitro].
Knecht M; Lipkin G
Dermatologica; 1974; 148(5):275. PubMed ID: 4418288
[No Abstract] [Full Text] [Related]
14. Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.
Wolnicka-Glubisz A; Noonan FP
Photochem Photobiol Sci; 2006 Feb; 5(2):254-60. PubMed ID: 16465311
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
[TBL] [Abstract][Full Text] [Related]
16. Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression.
Lentz KJ; Burns RP; Loeffler K; Feeney-Burns L; Berkelhammer J; Hook RR
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1063-9. PubMed ID: 6874271
[TBL] [Abstract][Full Text] [Related]
17. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo.
Liu X; Chen D; Xie L; Zhang R
J Pharm Pharmacol; 2002 Aug; 54(8):1083-9. PubMed ID: 12195822
[TBL] [Abstract][Full Text] [Related]
18. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
19. Growth and metastasis of hamster melanoma following transplantation into athymic mice.
Schleicher RL; Green AW; Beattie CW
Cancer Res; 1987 Aug; 47(16):4465-70. PubMed ID: 3607776
[TBL] [Abstract][Full Text] [Related]
20. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
